-transparent.png){kind=logo}
The results of treatment of supraventricular paroxysmal tachycardia by the intravenous administration of ATP in a dose of 10-30 mg make it possible to consider ATP as an agent of choice for relieving supraventricular paroxysmal tachycardia under conditions of emergency medical aid.
Related Publications
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
April 1992,
Annals of emergency medicine,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
March 1990,
Annals of emergency medicine,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
January 1980,
Sovetskaia meditsina,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
March 1986,
British heart journal,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
March 1983,
Australian paediatric journal,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
May 1972,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
May 1976,
Rational drug therapy,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
February 1975,
Lancet (London, England),
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
April 1989,
Anaesthesia,
Iu I Nesterov, and
A G Kiselev, and
L I Suvorova, and
T S Trushina, and
V I Boĭko
May 2004,
Revue medicale de Liege,
